AU669874B2 - Preparation of 2-amino-6-chloropurine - Google Patents

Preparation of 2-amino-6-chloropurine

Info

Publication number
AU669874B2
AU669874B2 AU33654/93A AU3365493A AU669874B2 AU 669874 B2 AU669874 B2 AU 669874B2 AU 33654/93 A AU33654/93 A AU 33654/93A AU 3365493 A AU3365493 A AU 3365493A AU 669874 B2 AU669874 B2 AU 669874B2
Authority
AU
Australia
Prior art keywords
process according
guanine
chloropurine
amino
phase transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU33654/93A
Other versions
AU3365493A (en
Inventor
Christopher Robert James Killen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU3365493A publication Critical patent/AU3365493A/en
Application granted granted Critical
Publication of AU669874B2 publication Critical patent/AU669874B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

Preparation of 2-am1 no-6-chloropurine
This invention relates to a process for the preparation of a compound useful as an intermediate in the preparation of pharmaceutical compounds.
The compound 2-amino-6-chloropurine of formula (I):
(I)
is a useful intermediate in the preparation of nucleoside analogue antiviral agents, such as penciclovir and famciclovir, described in EP-A-141927 (Example 1) and EP-A-182024 (Example 2). The intermediate is 9-substituted with an appropriate side chain precursor, followed by conversion of the 6-chloro moiety to a hydroxy (a guanine) or hydrogen (a 2-aminopurine).
EP-A-203685 (Beecham Group p.l.c.) describes a process for preparing a compound of formula (I) as hereinbefore defined, which process comprises reacting guanine with a chlorinating agent in the presence of a phase transfer catalyst containing chloride ions. EP-A-433846 (Hoechst Aktiengesellschaft) describes a corresponding process for preparing the 2-acylated derivative, involving chlorination of 2,9-diacylguanine and subsequent removal of the 9- acyl group by hydrolysis.
The reaction is preferably carried out in a polar inert organic solvent such as acetonitrile, tetrahydrofuran, dioxan, nitromethane, diglyme, dimethoxyethane, ordichloromethane. Acetonitrile is highly preferred. Suitable phase transfer catalysts include tetrasubstituted ammonium chlorides. Examples of ammonium substituents include C2-12 aik i, usually C2-4 alkyl, or phenyl or benzyl. Other possible phase transfer catalysts include tetra-substituted phosphonium chlorides wherein examples of the substitutents are as defined above for ammonium chlorides. Preferably the phase transfer catalyst is tetraethylammonium chloride.
The phase-transfer catalyst is preferably present in an amount of from 1 to 3 equivalents of the compound of formula (II) and preferably from 1 to 2 equivalents.
A preferred chlorinating agent is phosphorus oxychloride.
Preferably the chlorinating agent is present in an amount of from 2-10 preferably from 3-6 molar equivalents of the guanine derivative.
The reaction may be effected in the presence of a weak base, such as a tertiary amine, for example N,N-dimethylaniliπe or diethylaniline or triethylamine- The base is usually present in an approximately molar equivalent amount with respect to the guanine derivative. Alternatively, a catalytic amount of water may be added to the reaction mixture. When acetonitrile is the solvent, added base may not be necessary, but is preferred.
The reaction is preferably carried out at an elevated temperature of from 30-100°C, most preferably under reflux and/or with ultrasonication at 50-70°C.
Preferably the reaction is allowed to proceed for a period of greater than half an hour, usually less than 30 hours.
We have now discovered that the compound of formula (I) may be prepared from 2,9-diacylguanine. Accordingly, the present invention provides a process for preparing 2-amino- 6-chloropurine, which process comprises reacting a 2,9-diacylated derivative of guanine with a chlorinating agent in the presence of a phase transfer catalyst containing chloride ions, and thereafter removing the 9-acyl group and the 2-acyl group by hydrolysis.
The reaction is described in EP-A-203685 and EP-A-433846, which are incorporated herein by reference, except that methyltriethylammonium chloride is a preferred phase transfer catalyst; the amount of phosphorus oxychioride may be reduced to 2-4 equivalents, and the reaction time can be reduced.
If the removal of the 9-acyl group generally occurs at ambient temperature (below 30°C), but higher temperatures and reaction times (80-100°C, 1 -2 hours) are needed for removal of the 2-acyl group. Aqueous sodium hydroxide is a suitable basic medium for the hydrolysis.
The following example illustrates the invention.
Example
Diacetyl guanine (8.0g, 0.034 moles), triethyimethylammonium chloride (15.45g, 0.102 moles), and triethylamine (4.74 mis, 0.034 moles) were heated together with stirring in acetonitrile (70mls) to 50°C. Phosphorus oxychioride (6.34 mis, 0.068 moles) was then added and stirring continued for 4 hours. The reaction mixture was cooled and then added to aqueous sodium hydroxide solution (20g in 300mls water). The reaction mixture was heated to 80°C for 2 hours and then the volume made up to 300 mis with water. The mixture was cooled to 25°C and the pH adjuster to 7 using 10% hydrochloric acid. The resulting slurry was stirred for fifteen minutes and the product filtered off and washed with water 30 mis and then dried at 80°C under vacuum to give a cream/off white coloured product.
Weight 2-amino-6-chioropurine 4.69 g (74.6% yield).

Claims (6)

Ciaims
1. A process for preparing 2-amino-6-chloropurine, which process comprises reacting a 2,9-diacylated derivative of guanine with a chlorinating agent in the presence of a phase transfer catalyst containing chloride ions, and thereafter removing the 9-acyl group and the 2-acyl group by hydrolysis.
2. A process according to claim 1 , as described in EP-A-203685 and EP-A-433846.
3. A process according to claim 2, wherein the chlorinating agent is phosphorus oxychioride and the phase transfer catalyst is methyltriethyiammonium chloride.
4. A process according to in claim 3, wherein the amount of phosphorus oxychioride is 2-4 equivalents with respect to the 2,9-acylated guanine.
5. A process according to claim 1 , wherein aqueous sodium hydroxide is used as the basic medium for the hydrolysis.
6. A process according to claim 1 , substantially as described herein with reference to the Example.
AU33654/93A 1992-01-30 1993-01-28 Preparation of 2-amino-6-chloropurine Ceased AU669874B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9201961 1992-01-30
GB929201961A GB9201961D0 (en) 1992-01-30 1992-01-30 Pharmaceuticals
PCT/GB1993/000185 WO1993015075A1 (en) 1992-01-30 1993-01-28 Preparation of 2-amino-6-chloropurine

Publications (2)

Publication Number Publication Date
AU3365493A AU3365493A (en) 1993-09-01
AU669874B2 true AU669874B2 (en) 1996-06-27

Family

ID=10709516

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33654/93A Ceased AU669874B2 (en) 1992-01-30 1993-01-28 Preparation of 2-amino-6-chloropurine

Country Status (10)

Country Link
EP (1) EP0625154A1 (en)
JP (1) JPH07503246A (en)
KR (1) KR950700299A (en)
AU (1) AU669874B2 (en)
CA (1) CA2117435A1 (en)
GB (1) GB9201961D0 (en)
MX (1) MX9300482A (en)
NZ (1) NZ246677A (en)
WO (1) WO1993015075A1 (en)
ZA (1) ZA93615B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4231036A1 (en) * 1992-09-17 1994-03-24 Basf Ag Process for the preparation of 2-amino-6-halopurines
JPH07133276A (en) * 1993-09-17 1995-05-23 Jiyuuzen Kagaku Kk Production of 2-acetylamono-6-chloropurine
DE4415196C1 (en) * 1994-04-30 1995-04-27 Boehringer Ingelheim Kg Improved process for the preparation of 2-amino-6-chloropurine and 2-acylamino-6-chloropurines
CA2189088C (en) 1995-11-09 2005-09-20 Masatoshi Sakai 2-amino-6-chloropurine and method for preparing the same
JP4223408B2 (en) 2002-04-04 2009-02-12 住友化学株式会社 Method for producing 2,6-dihalopurine
CN102336755B (en) * 2011-09-30 2013-03-27 浙江工业大学 Chemical synthesis method of 6-chloropurine
CN113214260B (en) * 2021-05-10 2022-04-01 上海凌凯医药科技有限公司 Synthesis method of 2-acetamido-9-acetyl purine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203685A2 (en) * 1985-03-23 1986-12-03 Beecham Group Plc Process for the preparation of 2-amino-6-chloro-purine
EP0433846A1 (en) * 1989-12-16 1991-06-26 Hoechst Aktiengesellschaft Process for the preparation of 2-acylamino-6-halogeno-purine from 2,9-diacylguanine
AU655002B2 (en) * 1991-01-31 1994-12-01 Novartis International Pharmaceutical Ltd Process for the preparation of 2-amino-6-chloropurine or a 2-acylated derivative thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (en) 1983-08-18 1991-12-05 Beecham Group Plc ANTIVIRAL GUANINE DERIVATIVES.
DE3582399D1 (en) 1984-09-20 1991-05-08 Beecham Group Plc PURINE DERIVATIVES AND THEIR PHARMACEUTICAL USE.
DE3941658A1 (en) * 1989-12-16 1991-06-20 Hoechst Ag METHOD FOR PRODUCING 2-ACYLAMINO-9-ACYL-6-HALOGEN PURIN

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203685A2 (en) * 1985-03-23 1986-12-03 Beecham Group Plc Process for the preparation of 2-amino-6-chloro-purine
EP0433846A1 (en) * 1989-12-16 1991-06-26 Hoechst Aktiengesellschaft Process for the preparation of 2-acylamino-6-halogeno-purine from 2,9-diacylguanine
AU655002B2 (en) * 1991-01-31 1994-12-01 Novartis International Pharmaceutical Ltd Process for the preparation of 2-amino-6-chloropurine or a 2-acylated derivative thereof

Also Published As

Publication number Publication date
EP0625154A1 (en) 1994-11-23
NZ246677A (en) 1996-02-27
AU3365493A (en) 1993-09-01
ZA93615B (en) 1993-11-26
GB9201961D0 (en) 1992-03-18
CA2117435A1 (en) 1993-08-05
KR950700299A (en) 1995-01-16
JPH07503246A (en) 1995-04-06
WO1993015075A1 (en) 1993-08-05
MX9300482A (en) 1994-07-29

Similar Documents

Publication Publication Date Title
US6870053B2 (en) Chloropyrimidine intermediates
EP0569421B1 (en) Process for the preparation of 2-amino-6-chloropurine and derivatives
GB1595337A (en) Synthesis of methotrexate
AU669874B2 (en) Preparation of 2-amino-6-chloropurine
EP0203685B1 (en) Process for the preparation of 2-amino-6-chloro-purine
AU634564B2 (en) Process for preparing 2,5-diamino-4,6-dichloropyrimidine
JP2672874B2 (en) Manufacturing method of cytosine
JPH0645620B2 (en) Method for methylating xanthines
JP2724881B2 (en) Improved method for precipitating cytosine from alkaline solution with sulfuric acid
GB2160204A (en) Preparation of N-methyl-1-alkylthio-2-nitroethenamines
JPH07300480A (en) Improved process for producing 2-amino-6-chloropurine and 2-acylamino-6-chloro-purine
JPH0578358A (en) New method for preparing and purififying compound
JP2002069050A (en) Method for producing hydrazocarbonamide